The Histamine-Associated Inflammatory Landscape of Endometriosis: Molecular Profiling of HDC, HRH1-HRH4, and Cytokines Across Lesion Subtypes
Open accessThe DOI matches its Crossref record; 43 of the 53 references it cites were found in a registry or an index, and 6 are not checked yet; 3 of the 53 sources its claims cite were checked for support.
Abstract
Pain in endometriosis involves not only nociceptive but also neuropathic and neurogenic components, reflecting its complex nature. Histamine, a biogenic amine, has emerged as a critical mediator connecting inflammation and nerve sensitization. This study aimed to characterize histamine receptor (HRH1–HRH4) expression, localization, and related inflammatory mediators in peritoneal, deep infiltrating, and ovarian endometriosis. Gene expression datasets were analyzed, and immunofluorescence staining of endometriotic lesions was performed using immune and neuronal markers. Histamine and its metabolite methylhistamine were quantified in serum, peritoneal fluid, and urine samples. HDC expression was significantly elevated in all endometriotic lesions compared with controls (all p < 0.01), paralleling increased IL-6, COX-2, NGF, and NGFR levels (p < 0.0001). In contrast, HRH1–HRH4 transcript levels showed no significant differences between groups. Immunofluorescence demonstrated robust HRH1–HRH4 protein expression in epithelial, immune, and nerve fibers, with subtype-specific colocalization patterns. Serum histamine concentrations were significantly higher in endometriosis patients than controls (0.484 vs. 0.153 ng/mg protein; p = 0.0014), whereas peritoneal histamine and urinary methylhistamine showed no group differences. Overall, these findings highlight histamine signaling as a potentially important component of endometriosis pathophysiology and point toward new directions for mechanistic studies and therapeutic exploration.
Verified 2026-10-11 · 6 references not checked yet
Overview
CoChat Summary
## TL;DR
This study maps histamine-related biology across endometriosis subtypes and finds elevated HDC plus inflammatory mediators, along with histamine receptor protein expression in immune cells and nerve fibers within lesions. It also reports higher serum histamine in endometriosis, but no difference in peritoneal fluid histamine or urinary methylhistamine versus controls.
## Key findings
- In GEO dataset analysis (330 patients with endometriosis, 62 controls), HDC expression was higher in peritoneum (9.40, 9.07–9.62), peritoneal endometriosis (8.71, 8.08–9.27), deep infiltrating endometriosis (9.38, 8.79–9.92), and ovarian endometriosis (8.33, 8.00–9.07) than in control tissue (7.01, 6.54–8.37) and patient endometrium (7.24, 6.77–7.51; all reported significant comparisons).
- IL-6, COX2, NGF, and NGFR were also increased in multiple lesion subtypes; for example, COX2 was highest in deep infiltrating endometriosis (8.86, 8.12–9.76) versus controls (7.08, 6.81–7.38; p < 0.0001), and NGFR was elevated in patient peritoneum (7.48, 7.10–7.89), peritoneal endometriosis (7.24, 6.88–7.66), and deep infiltrating endometriosis (6.99, 6.65–7.48) versus controls and patient endometrium (all p < 0.0001).
- Transcriptomic analysis found no statistically significant differences in HRH1–HRH4 mRNA across groups, but immunofluorescence detected all four receptors in lesions: in peritoneal endometriosis, receptor expression was higher than controls for HRH1 (5.17 vs 1.80; p = 0.01), HRH2 (22.48 vs 0.61; p < 0.0001), HRH3 (7.76 vs 2.85; p = 0.0045), and HRH4 (28.67 vs 2.16; p < 0.0001).
- Histamine was found in a more systemic pattern: serum histamine was higher in endometriosis patients (0.484 ng/mg) than controls (0.153 ng/mg; p = 0.0014), while peritoneal fluid histamine did not differ (0.463 ng/mg vs 0.554 ng/mg; p = 0.1314) and urinary methylhistamine also did not differ (109.6 ± 38.94 μg/g creatinine vs 113.0 ± 45.55 μg/g creatinine; p = 0.9534).
## Methods
- The study combined four analyses: re-analysis of the public GEO dataset GSE141549, immunofluorescence on lesion/control tissues, ELISA measurement of histamine in serum and peritoneal fluid, and HPLC measurement of urinary methylhistamine.
- Tissue immunofluorescence used 30 endometriosis samples total (10 each of peritoneal, deep infiltrating, and ovarian endometriosis) and 15 location-matched controls; gene-expression analysis used 330 endometriosis patients and 62 controls.
- Main analyses included Kruskal–Wallis/Dunn’s, Mann–Whitney U, and Spearman correlation tests; receptor localization was assessed with co-staining for CD45, PGP9.5, substance P, TH, and VIP.
## Limitations
- The paper explicitly states that the sample size per lesion subtype was relatively small, receptor quantification was semi-quantitative, the study was cross-sectional, and it did not perform functional assays to test downstream signaling or receptor-specific pharmacologic responses.
- The authors note that the public GEO dataset may be affected by batch effects or sample heterogeneity.
- Evident from the text: some control groups were small, including n = 5 for each subtype-matched tissue control in the immunofluorescence work and n = 10 controls for peritoneal fluid, which may limit precision.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
2 Valid · 0 Not valid · 26 Not checked · 91 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“They also align with previous reports of increased mast cell density and degranulation within endometriotic lesions and their spatial association with sensory nerve fibers [ 9 , 11 , 22 ], suggesting that histamine release serves as a key interface between immune activation and nociceptive signaling.”
What the sources say
- Not checked yetcites [9] Arnold, 2012, Imbalance between sympathetic and sensory innervation in peritoneal endometriosis, Brain Behav. Immun. source
- Not checked yetcites [11] Binda, 2017, Targeting mast cells: A new way to treat endometriosis, Expert. Opin. Ther. Targets source
- Supportedcites [22] Anaf, 2006, Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis, Fertil. Steril. source
The DISCUSSION of our copy reports exactly what the citing sentence attributes: a significantly greater number of mast cells in endometriotic lesions than controls, more degranulating mast cells (especially in deep infiltrating lesions), and a greater proportion of mast cells located ≤25 μm from nerve structures, including degranulating mast cells within the perineurium (DISCUSSION; Abstract; Fig. 2 legend). The same DISCUSSION states the mechanistic clause directly — 'Histamine is a key mediator released by activated mast cells. It can sensitize nociceptors' — and the Fig. 2 discussion adds that histamine-receptor antagonists suppressed hyperalgesia in animal models. The source frames its endometriosis-specific extension as speculation ('we speculate that mast cell products... contribute to the development of pain'), which matches the citing sentence's hedged 'suggesting that'. (LLM, conf=0.85)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The presence of HRH2- and HRH3-positive fibers within both sensory and autonomic systems in deep infiltrating endometriosis suggests that histamine may also contribute to visceral dysregulation and autonomic dysfunction, components increasingly recognized in endometriosis-associated pain syndromes [ 1 , 7 ].”
What the sources say
- Could not verifycites [1] Mechsner, S. (2022). Endometriosis, an Ongoing Pain-Step-By-Step Treatment. J. Clin. Med., 11. sourceExperimental — accuracy not yet measured
Searched our copy for histamine receptors (HRH2/HRH3), histaminergic or autonomic nerve fibers in deep infiltrating endometriosis, and histamine-driven visceral/autonomic dysfunction; no passage addresses any of these. The only mention of histamine is in the Diet section (3.5, p. 8), where vitamin D's analgesic effect is ascribed 'probably due to a reduced histamine release' — a different point about a supplement's mechanism, not about histaminergic fibers or autonomic dysregulation in DIE. The paper's pathophysiology sections (Introduction, pp. 2-3; Conclusions, p. 10) discuss nociceptive/nociplastic pain, central sensitization, neurogenic inflammation and overlapping syndromes such as IBS and painful bladder syndrome, but never link histamine to visceral or autonomic dysfunction. Our copy is complete (not truncated), so the claim's specific point is simply absent rather than contradicted. (LLM, conf=0.72)
- Not checked yetcites [7] Velho, R.V., Taube, E., Sehouli, J., and Mechsner, S. (2021). Neurogenic Inflammation in the Context of Endometriosis—What Do We Know?. Int. J. Mol. Sci., 22. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, deep infiltrating endometriosis lesions displayed fewer CD45-positive cells (2.67, 1.38–4.46) than controls (10.94, 1.66–14.59, p = 0.045; Figure 4 G).”
plainn = 5 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Quantitative analysis demonstrated a significantly higher expression of all four receptors in peritoneal endometriosis compared with control tissues (HRH1: 5.17, 1.04–13.96 vs. control: 1.80, 0.05–6.48; p = 0.01; HRH2: 22.48, 9.43–31.35 vs. control: 0.61, 0.18–4.89; p < 0.0001; HRH3: 7.76, 1.73–15.78 vs. control: 2.85, 0.79–3.69; p = 0.0045; HRH4: 28.67, 10.75–46.40 vs. control: 2.16, 0.15–12.51;”
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ovarian endometriosis also exhibited significantly higher COX2 levels compared to controls ( p = 0.0355).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 119 claims and to verify the 50 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 45
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“HRH2-positive nerves displayed a similar distribution pattern, with an average of 33.33% colocalization across the three neuronal markers. More specifically, HRH2-positive fibers overlapped with 36.36% of sensory and sympathetic markers and 45.45% of parasympathetic markers.”
Reported 33.33 · recomputed 39.39
Citations
Cites
Histamine and histamine intolerance
Maintz, L., & Novak, N. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1185 · Cited by 864 · cited 1×
“Within the peritoneal cavity, histamine is rapidly degraded by enzymes such as histamine-N-methyltransferase (HNMT) and diamine oxidase (DAO), leading to low measurable concentrations despite strong local HDC expression and mast-cell activation [49,50].”
Thangam, E. B., Jemima, E. A., Singh, H., Baig, M. S., Khan, M., Mathias, C. B., Church, M. K., & Saluja, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01873 · Cited by 534 · cited 3×
“While its inflammatory roles include the recruitment and activation of immune cells (Mast cells, eosinophils, and NK cells), the stimulation of pro-inflammatory cytokine production (IL-6 and TNF-alpha), and the dysregulation of blood vessel formation, enabling immune cell infiltration [14,15].”
Role of Histamine in Modulating the Immune Response and Inflammation
Branco, A. C. C. C., Yoshikawa, F. S. Y., Pietrobon, A. J., & Sato, M. N. (2018) · Mediators of Inflammation · doi:10.1155/2018/9524075 · Cited by 388 · cited 3×
“While its inflammatory roles include the recruitment and activation of immune cells (Mast cells, eosinophils, and NK cells), the stimulation of pro-inflammatory cytokine production (IL-6 and TNF-alpha), and the dysregulation of blood vessel formation, enabling immune cell infiltration [14,15].”
Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis
Anaf, V., Chapron, C., El Nakadi, I., De Moor, V., Simonart, T., & Noël, J.-C. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.057 · Cited by 258 · cited 2×
“They also align with previous reports of increased mast cell density and degranulation within endometriotic lesions and their spatial association with sensory nerve fibers [9,11,22], suggesting that histamine release serves as a key interface between immune activation and nociceptive signaling.”
Bakker, R. A., Schoonus, S. B. J., Smit, M. J., Timmerman, H., & Leurs, R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.1133 · Cited by 256
Nerve growth factor stimulates the development of substance P in sensory ganglia
Kessler, J. A., & Black, I. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.649 · Cited by 198 · cited 1×
“Additionally, histamine is known to stimulate nerve growth factor (NGF) expression, which, in turn, enhances the synthesis of neuropeptides such as substance P (SP) and calcitonin gene-related peptide (CGRP)—critical modulators of pain transmission [23,24].”
Inflammatory Mediators and Pain in Endometriosis: A Systematic Review
Machairiotis, N., Vasilakaki, S., & Thomakos, N. (2021) · Biomedicines · doi:10.3390/biomedicines9010054 · Cited by 164 · cited 1×
“This upregulation was accompanied by increased expression of inflammatory mediators, including IL-6 and COX2, as well as NGF and NGFR, which are known to mediate neurogenic inflammation and pain sensitization [7,34].”
Histamine, histamine receptors, and neuropathic pain relief
Obara, I., Telezhkin, V., Alrashdi, I., & Chazot, P. L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14696 · Cited by 159 · cited 1×
“In contrast, serum histamine was significantly elevated, indicating systemic dysregulation that could contribute to inflammation, neuronal sensitization, and endometriosis-associated pain [46,47].”
Histamine, Histamine Receptors, and their Role in Immunomodulation: An Updated Systematic Review
Shahid, M., Tripathi, T., Sobia, F., Moin, S., Siddiqui, M., & Khan, R. A. (2009) · The Open Immunology Journal · doi:10.2174/1874226200902010009 · Cited by 139 · cited 1×
“…that histamine receptor abundance and signaling can be modulated by post-transcriptional mechanisms (e.g., microRNA regulation, mRNA stability) and post-translational processes such as receptor trafficking, membrane recycling, and ligand-dependent stabilization in inflammatory tissues [37–39].”
Imbalance between sympathetic and sensory innervation in peritoneal endometriosis
Arnold, J., Barcena de Arellano, M. L., Rüster, C., Vercellino, G. F., Chiantera, V., Schneider, A., & Mechsner, S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.004 · Cited by 132 · cited 2×
“A key feature observed in endometriosis lesions is the increased density of sensory nerve fibers in proximity to immune cells such as mast cells [9–11].”
Self-citationHistamine receptor 2 modifies dendritic cell responses to microbial ligands
Frei, R., Ferstl, R., Konieczna, P., Ziegler, M., Simon, T., Rugeles, T. M., Mailand, S., Watanabe, T., Lauener, R. P., Akdiş, C. A., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.013 · Cited by 125 · cited 1×
“HRH2 appears to play a weaker or indirect role in epithelial cytokine induction, primarily by modulating immune cells such as dendritic cells [42].”
Alternative splicing of G protein-coupled receptors: physiology and pathophysiology
Markovic, D., & Challiss, R. A. J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0093-4 · Cited by 110 · cited 1×
“…that histamine receptor abundance and signaling can be modulated by post-transcriptional mechanisms (e.g., microRNA regulation, mRNA stability) and post-translational processes such as receptor trafficking, membrane recycling, and ligand-dependent stabilization in inflammatory tissues [37–39].”
Functional characterization of histamine H4 receptor on human mast cells
Jemima, E. A., Prema, A., & Thangam, E. B. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.007 · Cited by 106 · cited 1×
“HRH4-mediated mast cell activation is reported to regulate a mighty inflammatory cascade triggering the release of inflammatory mediators and the migration of inflammatory cells to the site of inflammation [15,18].”
Histamina, receptores de histamina e anti-histamínicos: novos conceitos
Criado, P. R., Criado, R. F. J., Maruta, C. W., & Filho, C. D. M. (2010) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962010000200010 · Cited by 104 · cited 1×
“HRH1-2 are low-affinity receptors, whilst HRH3-4 are high-affinity receptors, activating at low levels of histamine [19–21].”
Endometriosis, an Ongoing Pain—Step-by-Step Treatment
Mechsner, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020467 · Cited by 103 · cited 3×
“These lesions can lead to a variety of symptoms, including dysmenorrhea, both cyclic and acyclic lower abdominal pain, dysuria, dyspareunia, and infertility [1,5,6].”
Self-citationDETECTION OF HISTAMINE BY A NEW FLUORESCENT o -PHTHALALDEHYDE STAIN
JUHLIN, L., & Shelley, W. B. (1966) · Journal of Histochemistry & Cytochemistry · doi:10.1177/14.7.525 · Cited by 94 · cited 1×
“Previous attempts to stain mast cells with histamine in the 1960s also proved unsuccessful, underscoring the difficulty of this method [32,33].”
The histamine-cytokine network in allergic inflammation
Marone, G., Granata, F., Spadaro, G., Genovese, A., & Triggiani, M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01881-5 · Cited by 92 · cited 1×
“Nevertheless, these findings are consistent with a model in which histamine may contribute to the chronic inflammatory milieu of endometriosis by amplifying cytokine release and promoting neuroangiogenesis [35,36].”
Assessing the true prevalence of endometriosis: A narrative review of literature data
Harder, C., Velho, R. V., Brandes, I., Sehouli, J., & Mechsner, S. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15756 · Cited by 87 · cited 1×
“Endometriosis is a chronic, estrogen-dependent inflammatory condition that affects 7–10% of menstruating individuals worldwide [1,2].”
Self-citationInvolvement of mast cells in a mouse model of postoperative pain
Oliveira, S. M., Drewes, C. C., Silva, C. R., Trevisan, G., Boschen, S. L., Moreira, C. G., Cabrini, D. A., Cunha, C. D., & Ferreira, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.001 · Cited by 84 · cited 1×
“…diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperal-gesia [25,26], pelvic pain [27], inflammatory pain [28], and postoperative nociception [29], further supporting a central role for histamine-driven pathways in endometriosis-associated pain.”
Gabriel, M., Fey, V., Heinosalo, T., Adhikari, P. R., Rytkönen, K. T., Komulainen, T., Huhtinen, K., Laajala, T. D., Siitari, H., Virkki, A., et al. (2020) · Scientific Data · doi:10.1038/s41597-020-00623-x · Cited by 84 · cited 2×
“Through collaboration with the University of Turku, we evaluated gene expression and phenotypic data from patients with endometriosis and those without using the Gene Expression Omnibus (GEO) database GSE141549 [51,52].”
Role of Mast Cells in Male Chronic Pelvic Pain
Done, J. D., Rudick, C. N., Quick, M. L., Schaeffer, A. J., & Thumbikat, P. (2012) · Journal of Urology · doi:10.1016/j.juro.2011.11.116 · Cited by 82 · cited 1×
“…across diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperal-gesia [25,26], pelvic pain [27], inflammatory pain [28], and postoperative nociception [29], further supporting a central role for histamine-driven pathways in…”
Massaad, C. A., Safieh‐Garabedian, B., Poole, S., Atweh, S., Jabbur, S. J., & Saadé, N. E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.05.007 · Cited by 70 · cited 1×
“…diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperal-gesia [25,26], pelvic pain [27], inflammatory pain [28], and postoperative nociception [29], further supporting a central role for histamine-driven pathways in endometriosis-associated pain.”
Neurogenic Inflammation in the Context of Endometriosis—What Do We Know?
Velho, R. V., Taube, E., Sehouli, J., & Mechsner, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313102 · Cited by 62 · cited 3×
“…of HRH2-and HRH3-positive fibers within both sensory and autonomic systems in deep infiltrating endometriosis suggests that histamine may also contribute to visceral dysregulation and autonomic dysfunction, components increasingly recognized in endometriosis-associated pain syndromes [1,7].”
Self-citationTargeting mast cells: a new way to treat endometriosis
Binda, M. M., Donnez, J., & Dolmans, M.-M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1260548 · Cited by 61 · cited 3×
“A key feature observed in endometriosis lesions is the increased density of sensory nerve fibers in proximity to immune cells such as mast cells [9–11].”
Stephan, V., Zimmermann, A., Kühr, J., & Urbanek, R. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80147-2 · Cited by 58 · cited 1×
“This is important because it enables a more accurate assessment of methylhistamine levels, which can be influenced by factors such as hydration status and kidney function [30,31].”
Histamine intolerance: a metabolic disease?
Schwelberger, H. G. (2009) · Inflammation Research · doi:10.1007/s00011-009-0134-3 · Cited by 48 · cited 1×
“Within the peritoneal cavity, histamine is rapidly degraded by enzymes such as histamine-N-methyltransferase (HNMT) and diamine oxidase (DAO), leading to low measurable concentrations despite strong local HDC expression and mast-cell activation [49,50].”
MacLean, D. B., Bennett, B. A., Morris, M., & Wheeler, F. B. (1989) · Brain Research · doi:10.1016/0006-8993(89)91515-1 · Cited by 47 · cited 1×
“Additionally, histamine is known to stimulate nerve growth factor (NGF) expression, which, in turn, enhances the synthesis of neuropeptides such as substance P (SP) and calcitonin gene-related peptide (CGRP)—critical modulators of pain transmission [23,24].”
Zhu, T.-H., Zou, G., Ding, S.-J., Li, T.-T., Zhu, L.-B., Wang, J.-Z., Yao, Y.-X., & Zhang, X.-M. (2019) · Journal of Pain Research · doi:10.2147/jpr.s195909 · Cited by 43 · cited 2×
“Additional studies across diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperal-gesia [25,26], pelvic pain [27], inflammatory pain [28], and postoperative nociception [29], further supporting a central role for histamine-driven pathways in…”
Histamine alters gene expression in cultured human nasal epithelial cells
Takeuchi, K., Kishioka, C., Ishinaga, H., Sakakura, Y., & Majima, Y. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112127 · Cited by 39 · cited 1×
“In bronchial and nasal epithelial cells, HRH1 activation induces cytokines such as IL-8 and GM-CSF and modulates tight junction proteins, implicating HRH1 in epithelial-driven inflammatory responses [40,41].”
Expression of histamine receptor genes Hrh3 and Hrh4 in rat brain endothelial cells
Karlstedt, K. A., Jin, C., & Panula, P. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12173 · Cited by 36 · cited 1×
“H4HR modulates immune responses, but direct evidence in epithelial cells is scarce; it is known to regulate cytokine secretion in monocytes and brain endothelial cells [44,45].”
MAST CELL STAIN FOR HISTAMINE IN FREEZE-DRIED EMBEDDED TISSUE
Shelley, W. B., ÖHMAN, S., & PARNES, H. M. (1968) · Journal of Histochemistry & Cytochemistry · doi:10.1177/16.6.433 · Cited by 33 · cited 1×
“Previous attempts to stain mast cells with histamine in the 1960s also proved unsuccessful, underscoring the difficulty of this method [32,33].”
Khalilzadeh, E., Azarpey, F., Hazrati, R., & Saiah, G. V. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.011 · Cited by 29
Velho, R. V., Halben, N., Chekerov, R., Keye, J., Plendl, J., Sehouli, J., & Mechsner, S. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.04.012 · Cited by 28 · cited 1×
“Increasing evidence implicates neuroinflammatory mechanisms in its pathophysiology [7,8].”
Self-citationHatipoğlu, Ö. F., Nishinaka, T., Nishibori, M., Watanabe, M., Toyomura, T., Mori, S., Yaykaşlı, K. O., Wake, H., & Takahashi, H. K. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.02.006 · Cited by 28 · cited 1×
“Nevertheless, these findings are consistent with a model in which histamine may contribute to the chronic inflammatory milieu of endometriosis by amplifying cytokine release and promoting neuroangiogenesis [35,36].”
Endometriosis in transgender men: recognizing the missing pieces
Vallée, A., Féki, A., & Ayoubi, J.-M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1266131 · Cited by 27 · cited 1×
“While most commonly diagnosed in individuals of reproductive age, endometriosis has also been reported in postmenopausal and transgender patients, including those who have undergone hysterectomy, highlighting its complex and persistent nature [3,4].”
Histamine, histamine receptors, and anti-histamines in the context of allergic responses
Mandola, A. B., Nozawa, A., & Eiwegger, T. (2019) · LymphoSign Journal · doi:10.14785/lymphosign-2018-0016 · Cited by 26 · cited 1×
“HRH1-2 are low-affinity receptors, whilst HRH3-4 are high-affinity receptors, activating at low levels of histamine [19–21].”
Endo Belly: What Is It and Why Does It Happen?—A Narrative Review
Velho, R. V., Werner, F., & Mechsner, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227176 · Cited by 22 · cited 1×
“These lesions can lead to a variety of symptoms, including dysmenorrhea, both cyclic and acyclic lower abdominal pain, dysuria, dyspareunia, and infertility [1,5,6].”
Self-citationMatsubara, M., Ohmori, K., & Hasegawa, K. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000091599 · Cited by 19 · cited 1×
“In bronchial and nasal epithelial cells, HRH1 activation induces cytokines such as IL-8 and GM-CSF and modulates tight junction proteins, implicating HRH1 in epithelial-driven inflammatory responses [40,41].”
Marla, S., Mortlock, S., Heinosalo, T., POUTANEN, M. H., Montgomery, G. W., & McKinnon, B. D. (2023) · BMC Medicine · doi:10.1186/s12916-023-03166-1 · Cited by 18 · cited 1×
“Through collaboration with the University of Turku, we evaluated gene expression and phenotypic data from patients with endometriosis and those without using the Gene Expression Omnibus (GEO) database GSE141549 [51,52].”
The Role of Mast Cells in the Development and Advancement of Endometriosis
Makoui, M. H., Fekri, S. M., Makoui, R. H., Ansari, N. E., & Esmaeilzadeh, A. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70019 · Cited by 18 · cited 1×
“Among the mediators released by activated mast cells, histamine has garnered increasing attention due to its pro-inflammatory and nociceptive properties [12,13].”
Deep Infiltrating Endometriosis and Adenomyosis: Implications on Pregnancy and Outcome
Gruber, T. M., Ortlieb, L., Henrich, W., & Mechsner, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010157 · Cited by 17 · cited 1×
“These lesions can lead to a variety of symptoms, including dysmenorrhea, both cyclic and acyclic lower abdominal pain, dysuria, dyspareunia, and infertility [1,5,6].”
Self-citationPeng, H., Wang, J., Ye, X. Y., Cheng, J., Huang, C. Z., Li, L. Y., Li, T. Y., & Li, C. W. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0288-1 · Cited by 17 · cited 1×
“H4HR modulates immune responses, but direct evidence in epithelial cells is scarce; it is known to regulate cytokine secretion in monocytes and brain endothelial cells [44,45].”
Mao, X., Wang, J., Ding, S., Guo, X., Xu, X., Xu, P., & Zhang, X. (2025) · The FASEB Journal · doi:10.1096/fj.202501493r · Cited by 14 · cited 3×
“This is supported by a recent study [13], which showed that endometriotic cell–derived human β -defensin-2 (HBD-2) stimulates mast cell histamine release via MRGPRX2 (Mas-Related G-Protein Coupled Receptor X2), which then sensitizes TRPV1 through HRH1 in pain-sensory neurons.”
Molecular Aspects of Histamine Receptors
Mocking, T. A. M., Bosma, R., Rahman, S. N., Verweij, E. W. E., McNaught-Flores, D. A., Vischer, H. F., & Leurs, R. (2016) · The Receptors · doi:10.1007/978-3-319-40308-3_1 · Cited by 13
Hermann, K., Hertenberger, B., & Ring, J. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236493 · Cited by 13
Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity
Gao, M., Ooms, J. F., Leurs, R., & Vischer, H. F. (2024) · Biomolecules · doi:10.3390/biom14070761 · Cited by 12
1-methylhistamine as a potential biomarker of food histamine intolerance. A pilot study
Sánchez-Pérez, S., Celorio-Sardà, R., Veciana-Nogués, M. T., Latorre‐Moratalla, M. L., Comas-Basté, O., & Vidal‐Carou, M. C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.973682 · Cited by 12 · cited 2×
“Urinary methylhistamine, normalized to creatinine, did not differ between groups and showed no correlation with age or key symptoms, suggesting that it may not reliably reflect disease activity or histamine turnover in endometriosis [30].”
Schneider, E. H. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1427-7 · Cited by 3 · cited 1×
“Additional studies across diverse pain models have shown that mast-cell stabilizers and histamine-receptor antagonists reduce hyperal-gesia [25,26], pelvic pain [27], inflammatory pain [28], and postoperative nociception [29], further supporting a central role for histamine-driven pathways in…”
Hanuskova, E., & Plevková, J. (2013) · Acta Medica Martiniana · doi:10.2478/acm-2013-0004 · Cited by 1
Recurrence of endometriosis after hysterectomy
Rizk (2014) · Facts Views Vis. ObGyn
UnresolvedThe peritoneum—An important factor for pathogenesis and pain generation in endometriosis
Mechsner (2014) · J. Mol. Med.
UnresolvedFunctional characterization of histamine receptor subtypes in a human bronchial epithelial cell line
Muller (2006) · Int. J. Mol. Med.
UnresolvedHistamine metabolism disorder in pathogenesis of chronic pelvic pain in patients with external genital endometriosis
Orazov (2017) · Patol. Fiziol. I Eksperimental’naia Ter.
Unresolved
Cited by
Mo, Y., Li, M., Ye, W., Jiang, Z., Lin, X.-H., & Kewang, L. (2026) · Pharmaceuticals · doi:10.3390/ph19071074 · Cited by 3
“In addition, their close spatial association with nerve endings contributes to pain sensitization and the development of chronic pain [81,82].”
Santhamma, B., Chacon, J. A., Deemer, E. M., Stary, D., Hernandez, S. A., Subramani, R., Lakshmanaswamy, R., Nickisch, K. J., Batra, S., & Nair, H. B. B. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218845 · Cited by 1
Shi, S., Song, W., Wu, Z., Cheng, Y., Liu, H., Tian, F., & Li, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1827134
“…increased histamine levels and intimate contacts between mast cells, sensory nerve fi bers and endometriotic glands have been reported in peritoneal and deeply in fi ltrating lesions, where histamine signaling is thought to contribute to pain, angiogenesis and fi broblast activation (26).”
Diagnosis-dependent metabolic reprogramming of follicular fluid
Kurdi, C., Hesszenberger, D., Csabai, D., Lajtai, A., Lakatos, Á., Gödöny, K., Mauchart, P., Várnagy, Á., Kovács, G. L., & Kőszegi, T. (2026) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-026-01579-0
“Histidine plays a role in immune regulation and vascular permeability, processes that are known to be dysregulated in EM [31].”
GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review
Anastasiu, C. V., Dimienescu, O. G., Dull, A.-M., Grigorescu, O. D., Canditu, I., & Moga, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145440
“NGF [32,33] • Neurotrophic factor involved in sensory nerve sprouting, hyperinnervation, and neurogenic inflammation; • produced in part by macrophages and mast cells within lesion-associated inflammatory niches.”
Influential
Metadata
- Authors
- Velho, R. V., Freitag, J. H., Brueckner, A. M., Thalmeier, L., Pohl, J., & Mechsner, S.
- Affiliations
- Stiftung Charité (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Mechsner, Sylvia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2025-12-24
- Volume
- 27
- Issue
- 1
- Pages
- 212
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC12785993
- OpenAlex
- W7117133207
- Cited by
- 7
- References
- 53
- Citations by year
- 2026: 7
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- endometriosis, histamine, histamine receptors, histidine decarboxylase, methylhistamine, deep infiltrating endometriosis, endometrioma, peritoneal endometriosis, neurogenic inflammation, neuropathic pain, cytokines, interleukin-6, cyclooxygenase-2, nerve growth factor, NGF receptor, endometriosis-associated pain
- MeSH terms
- Receptors, Histamine H4, Adult, Ascitic Fluid, Endometriosis, Female, Histamine, Histidine Decarboxylase, Humans, Inflammation, Methylhistamines, Receptors, Histamine, Receptors, Histamine H1, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.